Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Koen Van Herck

Showing results (1-10 of 68) with videos related to

Pageof 7
Sort By:
Expert Review of Vaccines|June 5, 2004
A review of the efficacy, immunogenicity and tolerability of a combined hepatitis A and B vaccinePierre Van Damme, Koen Van Herck
The New England Journal of Medicine|May 21, 2004
Hepatitis A vaccineKoen Van Herck, Pierre Van Damme
The Pediatric Infectious Disease Journal|September 9, 2008
Benefits of early hepatitis B immunization programs for newborns and infantsKoen Van Herck, Pierre Van Damme
JAMA|July 15, 2005
Effect of hepatitis A vaccination programsPierre Van Damme, Koen Van Herck
Expert Review of Vaccines|August 25, 2005
Prevention of hepatitis A by Havrix: a reviewKoen Van Herck, Pierre Van Damme
Travel Medicine and Infectious Disease|February 15, 2007
A review of the long-term protection after hepatitis A and B vaccinationPierre Van Damme, Koen Van Herck
Best Practice & Research. Clinical Gastroenterology|February 4, 2009
Prevention of viral hepatitis (B and C) reassessedKoen Van Herck, A Vorsters, P Van Damme
Human Vaccines & Immunotherapeutics|December 16, 2020
Hepatitis A vaccination and its immunological and epidemiological long-term effects - a review of the evidenceChristian Herzog, Koen Van Herck, Pierre Van Damme
Journal of Medical Virology|September 15, 2011
Antibody persistence and immune memory in healthy adults following vaccination with a two-dose inactivated hepatitis A vaccine: long-term follow-up at 15 yearsKoen Van Herck, Jeanne-Marie Jacquet, Pierre Van Damme
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|June 6, 2003
Rapid protection and vaccination against hepatitis A for travellersBradley A Connor, Koen Van Herck, Pierre Van Damme
Pageof 7

Showing results (1-10 of 68) with videos related to

Sort By:
Pageof 7
Expert Review of Vaccines|June 5, 2004
A review of the efficacy, immunogenicity and tolerability of a combined hepatitis A and B vaccinePierre Van Damme, Koen Van Herck
The New England Journal of Medicine|May 21, 2004
Hepatitis A vaccineKoen Van Herck, Pierre Van Damme
The Pediatric Infectious Disease Journal|September 9, 2008
Benefits of early hepatitis B immunization programs for newborns and infantsKoen Van Herck, Pierre Van Damme
JAMA|July 15, 2005
Effect of hepatitis A vaccination programsPierre Van Damme, Koen Van Herck
Expert Review of Vaccines|August 25, 2005
Prevention of hepatitis A by Havrix: a reviewKoen Van Herck, Pierre Van Damme
Travel Medicine and Infectious Disease|February 15, 2007
A review of the long-term protection after hepatitis A and B vaccinationPierre Van Damme, Koen Van Herck
Best Practice & Research. Clinical Gastroenterology|February 4, 2009
Prevention of viral hepatitis (B and C) reassessedKoen Van Herck, A Vorsters, P Van Damme
Human Vaccines & Immunotherapeutics|December 16, 2020
Hepatitis A vaccination and its immunological and epidemiological long-term effects - a review of the evidenceChristian Herzog, Koen Van Herck, Pierre Van Damme
Journal of Medical Virology|September 15, 2011
Antibody persistence and immune memory in healthy adults following vaccination with a two-dose inactivated hepatitis A vaccine: long-term follow-up at 15 yearsKoen Van Herck, Jeanne-Marie Jacquet, Pierre Van Damme
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|June 6, 2003
Rapid protection and vaccination against hepatitis A for travellersBradley A Connor, Koen Van Herck, Pierre Van Damme
Pageof 7